By Simpson Global Media News Desk
The Federal Government is moving to assess whether billions of naira committed to Nigeria’s basic healthcare financing system are translating into measurable improvements in healthcare access and financial protection, as millions of Nigerians continue to face substantial out-of-pocket medical expenses.
The National Health Insurance Authority (NHIA) disclosed that the Federal Government has released N235 billion through the Basic Healthcare Provision Fund (BHCPF) over the past three years, making the assessment of the fund’s impact an increasingly important part of the country’s health-financing debate. The disclosure came ahead of the inaugural Nigeria Health Financing Research and Learning Forum, which begins in Abuja on Monday, September 28, 2026.
The development comes against a mixed picture in Nigeria’s health system.
On one hand, NHIA says health-insurance enrolment has risen above 23 million people, while targeted financing programmes have expanded support for maternal and newborn care, cancer treatment, HIV and tuberculosis services. On the other hand, the authority says out-of-pocket spending remains high, leaving many households exposed to heavy medical bills when they need treatment.
The two-day forum is expected to bring together policymakers, researchers, healthcare professionals, health economists and development partners to examine how Nigeria can make better use of available resources and strengthen the link between evidence, financing decisions and health outcomes.
Its theme is “Evidence and Learning for Nigeria’s Health Financing Future: Building a Locally Led Research and Learning Ecosystem.”
The meeting is significant because the question facing Nigeria is no longer simply how much money is being allocated to healthcare.
It is increasingly about what that money achieves.
Why the N235bn Review Matters
The Basic Healthcare Provision Fund was created to provide a financing mechanism for essential healthcare services and strengthen primary healthcare in Nigeria.
Under the National Health Act, the BHCPF is intended to support a basic minimum package of health services, strengthen primary healthcare facilities, support emergency medical treatment and contribute to public-health security. The Vulnerable Group Fund is also part of the wider financing architecture and is intended to help vulnerable groups access healthcare.
The NHIA says the Federal Government released N235 billion through the fund over the past three years.
BusinessDay reported earlier in September that cumulative disbursements through the BHCPF since its establishment had reached N339 billion, with N235 billion — roughly 70 per cent of that cumulative amount — released during the preceding three years.
The newer NHIA statement places emphasis on determining whether the increased flow of resources is producing measurable improvements.
That distinction matters in health financing.
An allocation is an input.
A functioning primary health centre, a patient receiving treatment without being pushed into financial distress, a pregnant woman receiving emergency obstetric care or a person obtaining essential medicines at an affordable cost represents an outcome.
The review therefore moves the conversation toward whether funding is reaching intended services and whether those services are producing results that can be demonstrated with reliable evidence.
Health Spending and Household Costs
For Nigerian households, the most immediate issue is often the amount they must pay when illness occurs.
Out-of-pocket expenditure refers to healthcare payments made directly by individuals or households rather than through insurance, government financing or other forms of prepayment.
When these payments are high, illness can become a financial event as well as a medical one.
A household may have to pay for consultation, laboratory tests, medicines, scans, hospital admission, surgery, transportation and follow-up care.
For chronic illnesses, the costs can continue for months or years.
The NHIA has acknowledged that high out-of-pocket expenditure remains a concern even as insurance enrolment expands beyond 23 million people.
This creates a central challenge for health-financing policy.
Expanding the number of people registered under an insurance programme is important, but enrolment alone does not necessarily guarantee that every medical need is fully covered.
The scope of a benefits package, provider availability, reimbursement arrangements, medicine prices, diagnostic costs and the ability of patients to obtain services when they need them all affect the actual level of financial protection.
The upcoming forum is therefore expected to consider not just coverage numbers but how financing mechanisms work in practice.
Insurance Coverage Has Passed 23 Million
The NHIA recently reported that more than 23 million Nigerians are enrolled in the national health-insurance system.
The authority described the increase as progress toward Universal Health Coverage and said it was expanding financial protection for people facing serious health and social challenges.
The authority also said its programmes supporting Comprehensive Emergency Obstetric and Newborn Care and its Fistula-Free Programme had reached more than 93,000 women and newborns as of August 2026.
That figure included 79,221 mothers, 7,500 newborns and 6,044 women treated for obstetric fistula, according to NHIA.
The authority reported that the programmes contributed to a reduction in facility-based maternal mortality case-fatality rates from 1,042 per 100,000 in 2024 to 810.
More than 40,000 women had also been enrolled under the Basic Health Care Provision Fund through the maternal-health financing arrangements, while NHIA said there were 273 empanelled Comprehensive Emergency Obstetric and Newborn Care facilities and 22 fistula centres involved in the programmes.
These figures illustrate one of the ways health financing can be translated into targeted services.
However, they also demonstrate why measurement is necessary.
A financing programme can report the amount spent and the number of beneficiaries reached, but policymakers still need to know whether the services were timely, effective, affordable and sustainable.
From Spending to Evidence
The central idea behind the new research and learning forum is to strengthen the use of evidence in financing decisions.
According to the organisers, the meeting will bring together policymakers, researchers, practitioners and partners to improve the way locally generated evidence informs health-financing policy, implementation and decision-making.
This approach recognises that health budgets are finite.
Government cannot necessarily fund every available medicine, diagnostic technology or treatment at the same level.
Decisions therefore have to be made about priorities.
Those decisions can be informed by evidence about effectiveness, affordability, population needs, equity and the ability of the health system to deliver a particular intervention.
The NHIA has identified Health Technology Assessment, or HTA, as one mechanism for supporting such decisions.
HTA involves evaluating the clinical effectiveness, cost, equity, ethical implications and health-system consequences of medicines, medical devices, diagnostics and procedures before decisions are made about coverage and pricing.
For Nigeria, the use of HTA represents an attempt to make health-financing decisions more systematic.
Instead of considering only the price of an intervention, policymakers can examine what health benefit it provides, who benefits, what alternatives exist and what the financial implications would be for the health system.
What Health Technology Assessment Can Do
Healthcare technology is not limited to sophisticated machines.
It includes medicines, diagnostic tests, procedures, devices and other interventions used to prevent, diagnose or treat disease.
Some interventions can be highly effective but extremely expensive.
Others may cost less while producing significant benefits.
Still others may be useful only for particular groups of patients.
HTA provides a framework for examining those differences.
The NHIA said it had already conducted assessments involving kidney replacement therapy, colorectal cancer screening and treatment for advanced liver cancer.
The objective is not simply to determine which treatment is cheapest.
A health-financing system also has to consider effectiveness and fairness.
For example, a treatment that costs more may be justified if it produces substantially better outcomes for patients and is affordable within the health system.
Conversely, a relatively expensive intervention with limited additional benefit may require closer examination before public funds are committed at scale.
The evidence generated through such assessments can therefore help policymakers make more transparent decisions about what should be financed.
Primary Healthcare at the Centre
The BHCPF is closely connected to Nigeria’s primary healthcare system.
Primary healthcare facilities are often the first point of contact between citizens and the formal health system.
They provide services such as immunisation, maternal and child health, basic diagnosis, health education, preventive services and treatment for common conditions.
When primary healthcare functions effectively, some conditions can be detected and treated before they become more severe and expensive.
When primary care is weak, patients may bypass local facilities and travel to secondary or tertiary hospitals.
That can increase costs for patients and put additional pressure on hospitals.
The NHIA's own description of BHCPF identifies strengthening primary healthcare as one of the fund's major objectives, including support for essential drugs, vaccines, consumables, maintenance, equipment, transportation and human resources.
The financing review is therefore relevant not only to Abuja-based policymakers but also to communities whose nearest healthcare facility may be a primary health centre.
The Question of Financial Protection
Universal Health Coverage is generally understood not simply as the ability to enter a health facility but as access to needed health services without suffering financial hardship.
That means financial protection is a central component.
Nigeria’s health-insurance expansion is consequently being assessed against the broader question of whether households are protected when they require healthcare.
The NHIA's September update makes the challenge explicit: more than 23 million people are enrolled, but out-of-pocket expenditure remains high.
This means the next phase of reform involves more than increasing enrolment.
It involves examining what people can actually obtain through their coverage.
A person may be formally insured but still have to pay for services outside the benefit package.
A covered service may also be difficult to obtain if there are too few accredited facilities nearby.
Provider payment arrangements can affect availability.
Medicine shortages can force patients to purchase drugs privately.
Diagnostic capacity can vary significantly between facilities.
All these factors influence the practical value of insurance coverage.
Why the Research Forum Is Timely
The timing of the forum is important because Nigeria's health sector is undergoing multiple reforms simultaneously.
The Federal Ministry of Health and Social Welfare has been working on health-system renewal, while the NHIA has been expanding coverage and developing financing mechanisms.
The government has also moved toward greater use of evidence in decisions about healthcare spending.
The September forum provides an opportunity to connect these initiatives.
Researchers can present evidence.
Policymakers can identify questions that require further research.
Health economists can analyse financing models.
Healthcare professionals can describe practical challenges.
Patients and civil-society organisations can contribute perspectives about how policies work at community level.
The organisers say the goal is to create a locally led research and learning ecosystem rather than relying entirely on evidence generated outside Nigeria.
Building Nigerian Research Capacity
Locally generated evidence can be important because health systems differ from country to country.
A financing model that works in another country may not automatically work in Nigeria.
Population size, geography, disease patterns, healthcare infrastructure, income distribution, medicine markets and the organisation of government all affect the way health policies operate.
Research conducted within Nigeria can therefore help answer questions specific to the country's circumstances.
For example, policymakers may need evidence on the most effective way to finance primary healthcare in rural communities.
They may need to understand why people who are eligible for insurance do not enrol.
They may need to determine why some patients remain exposed to large medical expenses despite being insured.
They may need evidence on which medicines or procedures produce the greatest benefit per naira spent.
They may also need to know which financing arrangements encourage healthcare providers to deliver high-quality services.
The research forum is designed to create a platform for such questions.
Linking Researchers With Decision-Makers
Research has limited value if it remains disconnected from policy.
A study may contain valuable evidence, but if the findings do not reach the people responsible for budgets and programmes, the evidence may have little practical impact.
The forum's emphasis on evidence and learning is therefore also about creating stronger links between researchers and government agencies.
The organisers include the NHIA, Federal Ministry of Health and Social Welfare, Health Strategy and Delivery Foundation, Nigeria Health Watch and the Alliance for Health Policy and Systems Research.
The collaboration brings together government institutions and organisations involved in health research and policy.
The expectation is that research questions can be connected more directly to actual financing decisions.
The Maternal-Health Example
Maternal and newborn healthcare provides a useful example of why financing mechanisms matter.
Pregnancy and childbirth can become medical emergencies with little warning.
A woman who develops severe bleeding, hypertension or another complication may require rapid access to specialised care.
If a household has to raise a large amount of money before treatment can begin, delays can occur.
The NHIA says its financing programme for Comprehensive Emergency Obstetric and Newborn Care is intended to remove out-of-pocket barriers for vulnerable women and newborns.
The reported reach of more than 93,000 women and newborns gives policymakers a measurable indicator of programme activity.
But continued monitoring is necessary to determine whether services are available when required, whether facilities have the necessary staff and equipment, and whether financing arrangements remain sustainable.
That is the broader principle behind health-financing evaluation.
Money should ultimately be connected to services and services to outcomes.
Cancer and Expensive Treatment
Cancer presents another difficult financing challenge.
Diagnosis and treatment can involve expensive medicines, imaging, laboratory tests, surgery, radiotherapy and prolonged follow-up.
The NHIA has recently expanded financial-protection measures involving cancer care and entered a partnership with Roche for selected oncology medicines under a cost-sharing arrangement. The authority said cancer-related benefits also include services such as mammography, CT and MRI scans, diagnostic tests and radiotherapy.
Cancer care illustrates why financing decisions require evidence.
A health system has to consider the cost of medicines and equipment while also examining whether patients can access diagnosis early enough for treatment to be effective.
It also has to consider geographical access.
A patient may technically be entitled to a service but live hundreds of kilometres from a facility capable of providing it.
Financing therefore interacts with infrastructure, workforce and technology.
HIV and Tuberculosis Coverage
The NHIA also reported that financial protection is being extended to people living with HIV and tuberculosis through support from the Global Fund's Resilient and Sustainable Systems for Health grant.
These conditions illustrate another feature of healthcare financing: some services require continuity over long periods.
Treatment interruption can have serious consequences for patients and can also undermine public-health objectives.
Financing mechanisms therefore have to account for continuity rather than focusing solely on one-time interventions.
That principle also applies to noncommunicable diseases such as hypertension, diabetes and cancer.
The Growing NCD Challenge
The financing discussion comes as Nigeria and other countries face increasing pressure from noncommunicable diseases.
The World Health Organization's 2026 World Patient Safety Day campaign focused specifically on safer care for people living with noncommunicable diseases.
WHO says people with chronic conditions are particularly exposed to potential harm because they often interact with healthcare systems repeatedly over long periods.
In Nigeria, WHO estimates that between 30 and 40 per cent of adults aged 30 to 79 live with hypertension. The organisation said many people remain undiagnosed, untreated or have uncontrolled blood pressure.
This creates a financing challenge because chronic conditions require continuing care.
A health system must support diagnosis, medication, monitoring, follow-up and management of complications.
WHO reported that Nigeria's first phase of a National Hypertension Control Initiative had made hypertension services available in 104 primary healthcare facilities across Kano and Ogun states, with more than 22,700 people diagnosed and 16,455 enrolled in care by the end of the first phase.
Such programmes demonstrate how financing, primary healthcare and disease management are interconnected.
Patient Safety Is Part of the Equation
The quality of healthcare cannot be measured solely by whether a patient reaches a facility.
The patient also needs safe and appropriate care.
WHO's 2026 patient-safety campaign identifies safer diagnosis, medication safety, communication, continuity of care, stronger health systems and meaningful patient participation as important areas for action.
This matters to health financing because an inexpensive service that produces poor outcomes is not necessarily good value.
Likewise, preventing avoidable harm can reduce costs associated with complications, repeated treatment and prolonged hospital stays.
Nigeria established a National Task Force on Clinical Governance and Patient Safety in 2026 following approval of its National Patient Safety and Care Quality Policy and Implementation Strategy in 2024, according to WHO.
The development connects financing with quality.
Public money has to support not only access to care but care that is safe and effective.
The Workforce Question
No health-financing system operates independently of the health workforce.
Nigeria's hospitals and primary healthcare facilities require doctors, nurses, pharmacists, laboratory scientists, community health workers, radiographers, technicians and other professionals.
The country is also dealing with workforce pressures.
The National Association of Resident Doctors has given the Federal Government a two-week ultimatum over unresolved welfare and professional issues, including remuneration, career progression, professional allowances, excessive workloads, manpower shortages and working conditions. The association warned that failure to resolve the issues could trigger industrial action.
The doctors also raised concerns about migration of healthcare professionals and called for improved infrastructure and equipment.
Although the resident doctors' dispute is separate from the health-financing forum, it highlights a related issue.
Funding health facilities without adequate personnel may limit the impact of investments.
A new piece of equipment cannot improve patient care if there is no trained professional available to operate it.
A financed programme also requires staff to administer it.
The Cost of Medical Technology
Medical technology can improve healthcare but can also increase costs.
Diagnostic imaging, cancer treatment, kidney replacement therapy and advanced surgical procedures require significant investment.
Nigeria's health system therefore faces a balancing challenge.
It must expand access to technologies that improve outcomes while ensuring that spending decisions remain sustainable.
This is one reason the NHIA is promoting Health Technology Assessment.
The authority says HTA can help determine the clinical, economic and health-system implications of interventions before decisions are made about coverage and pricing.
The research forum is expected to deepen discussion around these issues.
The BHCPF's Broader Purpose
The BHCPF is designed as more than a funding pool.
The NHIA says it supports the Basic Minimum Package of Health Services and is intended to strengthen primary healthcare, emergency medical treatment and public-health security.
The fund also includes mechanisms aimed at vulnerable populations.
According to NHIA, vulnerable groups covered by the wider architecture include children under five, pregnant women, people with disabilities, internally displaced persons, prisoners, refugees, victims of human trafficking and others.
This reflects an important principle in health financing: people with the greatest healthcare needs may not necessarily have the greatest ability to pay.
A financing system therefore has to consider both need and financial vulnerability.
Why Data Matters
Evaluating the N235 billion released through the BHCPF requires reliable data.
Policymakers need to know where money went, which facilities received it, what services were provided and which populations benefited.
They also need to distinguish between spending that produced immediate outputs and investments whose benefits may emerge over a longer period.
For example, purchasing essential medicines may have an immediate effect on service availability.
Training health workers may produce benefits over several years.
Building or renovating a facility may require significant expenditure before patients see direct benefits.
Good evaluation therefore requires more than a single headline figure.
It requires a system that tracks inputs, outputs, outcomes and longer-term effects.
Transparency and Public Confidence
Health financing is also connected to public confidence.
Citizens are more likely to trust healthcare reforms when they can see evidence of what programmes are achieving.
Clear information about funding, beneficiaries, services and outcomes can help researchers, journalists, civil-society organisations and citizens understand how public resources are being used.
The NHIA's decision to foreground research and evidence through the new forum is part of that broader accountability conversation.
The authority has said it wants health investments to deliver measurable results.
Measurement can therefore serve two purposes.
It helps government improve programmes.
It also provides information that allows the public and other stakeholders to assess progress.
What the Abuja Forum Will Examine
The inaugural Nigeria Health Financing Research and Learning Forum is scheduled for September 28 and 29.
Organisers say it will bring together leaders, policymakers, researchers, practitioners and partners to strengthen locally led research and improve how evidence is used in health-financing decisions.
The agenda is expected to examine questions around how limited resources should be allocated, how healthcare providers should be paid and how evidence can determine which treatments and services receive public funding.
Those questions are directly connected to the everyday experience of patients.
If financing decisions are better informed, policymakers can potentially identify where investment is most needed.
If provider payment mechanisms are designed effectively, facilities may have stronger incentives and capacity to deliver services.
If treatment decisions are guided by evidence, public funds can be directed toward interventions with demonstrated value.
The forum cannot resolve these issues by itself.
But it provides a formal platform for examining them.
The Role of States
Nigeria's healthcare system is not managed solely by the Federal Government.
States and local governments have important responsibilities in healthcare delivery, particularly at primary-care level.
That means federal financing initiatives must work within a system involving multiple levels of government.
The success of national health-financing policies can therefore depend on implementation at state and facility level.
Differences between states in population, infrastructure, revenue, disease patterns and health-system capacity can affect outcomes.
Research can help identify which financing arrangements work under different circumstances.
That is another reason locally generated evidence is important.
The Challenge of Sustainability
Health financing is not only about finding money for the current year.
A programme that depends on temporary funding can become difficult to sustain when the financing source disappears.
The long-term challenge is to develop financing arrangements capable of supporting essential services consistently.
The BHCPF receives federal government funding and can also receive support from development partners, while the NHIA operates insurance-related mechanisms.
Nigeria's broader health-financing strategy therefore involves multiple sources.
The challenge is ensuring that those sources work together rather than creating fragmented programmes that are difficult to coordinate.
What Patients May Ultimately Expect
For patients, the technical language of health financing eventually translates into a few practical questions.
Can I afford to see a doctor?
Can I obtain the medicine I need?
Can I access a diagnostic test?
Will my insurance cover the service?
If I need emergency treatment, can I receive it without first raising a large amount of money?
Is there a functioning facility close to my community?
Will there be a trained health worker available?
Will the care I receive be safe?
These are the real-world measures against which financing reforms are ultimately experienced.
The N235 billion figure is therefore important, but the amount itself is not the final measure of success.
The more consequential question is what Nigerians receive in return for the investment.
A Shift Toward Measuring Results
The Federal Government's decision to review the impact of BHCPF spending indicates a greater emphasis on measuring results rather than simply reporting allocations.
The NHIA has said the increased investment makes it important to determine whether spending is producing measurable improvements.
That approach can help identify both progress and gaps.
Where a programme is producing good results, evidence can support expansion.
Where results are weak, evaluation can help identify the problem.
The problem could be insufficient funding.
It could be delayed disbursement.
It could be weak procurement.
It could be a shortage of staff.
It could be poor infrastructure.
It could be inadequate monitoring.
Or it could be that the intervention itself needs redesign.
Research can help distinguish among those possibilities.
The Bigger Health-Financing Picture
Nigeria is attempting to expand health coverage while managing limited public resources and rising medical costs.
The country's population is large and geographically dispersed.
Its healthcare needs range from infectious diseases and maternal and child health to cancer, hypertension, diabetes and other chronic conditions.
This means the health system cannot concentrate on a single category of illness.
It needs financing arrangements that can support prevention, diagnosis, treatment, emergency care and long-term management.
At the same time, households need protection against the financial consequences of illness.
The expansion of health insurance to more than 23 million people is one part of that process.
The BHCPF is another.
The use of Health Technology Assessment represents another layer.
The new research forum adds an evidence and learning component.
Together, these developments form part of an evolving health-financing architecture.
The Road Ahead
The immediate next step is the two-day research and learning forum in Abuja.
The more difficult work will come afterward.
Research findings have to be converted into decisions.
Decisions have to be implemented.
Implementation has to be monitored.
Results have to be measured.
And policies may have to be adjusted when evidence shows that an intervention is not producing the expected outcome.
That process is gradual.
It also requires cooperation between government agencies, state authorities, healthcare providers, researchers, civil-society organisations, development partners and communities.
The NHIA has positioned the new forum as part of that process.
Its emphasis on locally led evidence reflects an attempt to make health-financing decisions more closely connected to Nigerian realities.
What the N235bn Review Could Reveal
The review of the N235 billion released through the BHCPF could provide important information about how the fund has operated over the past three years.
It could show where financing has produced improvements in service availability.
It could identify facilities or programmes requiring additional support.
It could reveal gaps between financial allocations and actual service delivery.
It could also help policymakers determine whether existing financing mechanisms are adequately protecting households from medical costs.
Those findings will matter beyond the BHCPF itself.
They could inform future health budgets, insurance policy, primary healthcare planning and decisions about which services should receive public financing.
The value of the review will ultimately depend on the quality of the evidence collected and how openly the findings are used.
Conclusion
Nigeria is entering a new phase in its health-financing conversation, with the Federal Government moving from the question of how much is being spent toward the more demanding question of what that spending is achieving.
The National Health Insurance Authority says N235 billion was released through the Basic Healthcare Provision Fund during the past three years, while health-insurance enrolment has risen beyond 23 million people. Yet the authority also acknowledges that high out-of-pocket expenditure continues to expose many households to substantial medical costs.
That combination of increased investment and continued financial pressure is the central issue confronting policymakers as the inaugural Nigeria Health Financing Research and Learning Forum begins in Abuja.
The forum is expected to bring together policymakers, researchers, health economists, practitioners and partners to examine how evidence can guide decisions about healthcare financing, provider payments, treatment coverage and the allocation of limited resources.
The government's use of Health Technology Assessment is another part of the emerging approach.
The NHIA says it has already conducted assessments involving kidney replacement therapy, colorectal cancer screening and advanced liver cancer treatment, illustrating how evidence can be applied to difficult decisions about what healthcare systems can sustainably finance.
Meanwhile, targeted financing programmes are expanding support for maternal and newborn health, cancer care, HIV and tuberculosis services.
NHIA says more than 93,000 women and newborns had been reached through its emergency obstetric and newborn care and fistula programmes by August 2026, including 79,221 women and 7,500 newborns.
The broader health system, however, continues to face pressures involving workforce availability, medical costs, infrastructure and patient safety.
The recent ultimatum issued by resident doctors over welfare, manpower and working conditions provides another reminder that financing is closely connected to the people and systems responsible for delivering care.
The task ahead is therefore broader than increasing the amount of money committed to healthcare.
Nigeria needs to know whether resources are reaching the right services, whether those services are reaching the people who need them, whether treatment is safe and effective, and whether families are adequately protected from financial hardship.
Those questions cannot be answered by one statistic.
They require reliable data, independent analysis, transparent monitoring and continued engagement with healthcare providers and patients.
The N235 billion released through the BHCPF provides a substantial basis for such an assessment.
The more important figure in the years ahead will be the measurable health improvement generated from it.
If the new research and learning framework succeeds in connecting evidence to financing decisions, it could help make that measurement more systematic.
For Nigerian households, the significance will ultimately be practical.
The success of health-financing reform will be experienced not in the size of a government announcement but in whether a patient can obtain necessary care without being pushed into financial distress, whether a primary health centre has the staff and medicines it needs, whether emergency treatment is available when it matters, and whether public resources produce better health outcomes.
That is the test now confronting Nigeria's evolving health-financing system as policymakers, researchers and health-sector stakeholders gather in Abuja to examine where the country's healthcare money is going — and what it is delivering.
Comments
Post a Comment